NSC |
Compound |
Enrichment |
Correlation |
NSC 730009 |
cis-2,5,6,12,13-Pentahydro-6-methyl-(8,9-methylenedioxy)-3-n itro-5,11-dioxo-11H-indeno[1,2-c]isoquinoline |
0.0135714101922724 |
0.044657007 |
NSC 748147 |
5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide |
0.0135714101922724 |
0.29552998 |
NSC 750050 |
Null |
0.0135714101922724 |
0.31726799 |
NSC 753427 |
2.5-anhydro-1-(3,4,5-trimethoxyphenyl)-1-[3-hydroxy-4-methoxyphenyl]-1-desoxy-3.4:6.7-di-O-isopropylidene-L-glucohept-1-enitol |
0.0135714101922724 |
0.15554858 |
NSC 756483 |
SB-742864 |
0.0135714101922724 |
0.29672276 |
NSC 114346 |
Null |
0.0139796580235792 |
0.46675381 |
NSC 135880 |
Null |
0.0139796580235792 |
0.34495598 |
NSC 22709 |
v-Triazolo[4,5-d]pyrimidin-7-ol |
0.0139796580235792 |
0.43446259 |
NSC 275647 |
5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- |
0.0139796580235794 |
0.28603077 |
NSC 303861 |
L-Cysteine analog |
0.0139796580235794 |
0.46112702 |